How much funding has Elysium Health raised?

Elysium Health has raised $25.0M in total funding, most recently a Series B round.

Who are Elysium Health's investors?

Elysium Health's investors include Silicon Valley Bank, General Catalyst, Morningside Group, Breyer Capital.

When was Elysium Health founded?

Elysium Health was founded in 2014.

Where is Elysium Health headquartered?

Elysium Health is headquartered in New York, New York, United States.

What industry is Elysium Health in?

Elysium Health operates in Biotech.

How many employees does Elysium Health have?

Elysium Health has 11-50 employees.

Elysium Health

Translating aging research into accessible health products

New York, United States · Founded 2014 · $25.0M raised

Biotech

Headquarters: New York, New York
Employees: 11–50
Founded: 2014
Business Model: B2C

Website: elysium.com
Total Funding: $25.0M
Last Round: $20.0M Series BDec 2016
Rounds: 2

About

Elysium Health is a New York-based longevity supplement company founded in 2014 by MIT biologist Leonard Guarente and co-founders Dan Alminana and Eric Marcotulli. The company develops science-backed dietary supplements targeting cellular aging, brain health, immune function, metabolic health, and skin aging, with products including Basis (NAD+ precursor), Matter, Signal, Format, and Vision. Elysium also offers Index, an epigenetic biological age test.

Summary

Elysium Health is a Biotech company based in New York, United States, founded in 2014. It has raised $25.0M in total across 2 rounds, most recently a $20.0M Series B round in Dec 2016. Investors include Silicon Valley Bank, General Catalyst and Morningside Group.